Compare TOON & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOON | ACET |
|---|---|---|
| Founded | 2006 | 1947 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.1M | 33.5M |
| IPO Year | 2014 | 2017 |
| Metric | TOON | ACET |
|---|---|---|
| Price | $0.51 | $3.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $34.83 |
| AVG Volume (30 Days) | ★ 230.9K | 187.5K |
| Earning Date | 11-13-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.26 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $39,353,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.74 | ★ N/A |
| Revenue Growth | ★ 20.75 | N/A |
| 52 Week Low | $0.50 | $0.46 |
| 52 Week High | $1.29 | $9.97 |
| Indicator | TOON | ACET |
|---|---|---|
| Relative Strength Index (RSI) | 39.30 | 18.83 |
| Support Level | $0.50 | N/A |
| Resistance Level | $0.63 | $9.59 |
| Average True Range (ATR) | 0.02 | 0.34 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 16.27 | 3.39 |
Kartoon Studios Inc is a media company developing, producing, marketing, and licensing branded animated entertainment properties and consumer products for media and retail distribution. Its portfolio features programming for toddlers to tweens, including the preschool properties Rainbow Rangers for Nick Jr. and Llama Llama for Netflix, Stan Lee's Superhero Kindergarten, Shaq's Garage, toddler brand Baby Genius, STEM-based series Thomas Edison's Secret Lab, Warren Buffett's Secret Millionaires Club, and the new preschool show, Stan Lee's Superhero Kindergarten. Its channel is available on television and mobile devices through distribution platforms, including Comcast, Cox, DISH, Sling TV, Apple TV, Roku, Android TV, Tubi, Xumo, and Amazon Fire.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).